Utah-based ARUP Laboratories to start coronavirus antibody testing
This 2020 electron microscope image made available by the U.S. Centers for Disease Control and Prevention shows the spherical particles of the new coronavirus, colorized blue, from the first U.S. case of COVID-19. Antibody blood tests for the coronavirus could play a key role in deciding whether millions of Americans can safely return to work and school. (Hannah A. Bullock, Azaibi Tamin/CDC via AP)
Editor’s note: The Salt Lake Tribune is providing readers free access to critical local stories about the coronavirus during this time of heightened concern. See more coverage here. To support journalism like this, please consider donating or become a subscriber.
ARUP Laboratories, a national reference laboratory located at the University of Utah’s Research Park, has announced that they have begun COVID-19 antibody testing in Utah.
Utah Lt. Gov. Spencer Cox hailed the news as a “really big and exciting announcement,” one that will “help ... make better decisions and get people back to work much sooner.”
When someone is infected with the novel coronavirus, their body’s immune system begins to create antibodies, cells that work to prevent future infection. ARUP’s test looks for the presence of these antibodies. A positive test would signal that someone has already had COVID-19, even if they remained asymptomatic.
Whether someone who tested positive for the presence of antibodies would likely be immune to COVID-19 is an unanswered question with this particular disease, according to tweets
from Julio Delgado, the chief medical officer at ARUP. Those studies are ongoing, he said, and immunity may depend on the quantity of antibodies produced by the immune system in question.
Ray Firszt, an allergist-immunologist in Utah, told FOX 13
that he was optimistic about immunity.
“We believe that if you’ve been infected and you recover, and you develop IgG antibodies, so the memory antibody, that you are effectively immune to the virus. Which means you cannot get it again if you are exposed ... and you’re not contagious to someone else,” he said.
Antibody testing on a large scale can also give critical information to epidemiologists who want to understand how the coronavirus is spreading throughout a community. Standard testing protocols only measure those who were most sick — or most fortunate to get a test — and therefore miss sectors of spread within the state.
In high enough quantities, these tests can make clear how many people truly are infected with the virus, information the state can use in determining whether to continue policies like stay-at-home directives.
The tests aren’t available in great numbers right now, but ARUP is ramping up production. The plan is to increase testing capacity to support testing to the general public “in the next couple of weeks,” not just locally in Utah, but nationwide.
In the meantime, Delgado said that the first to receive the test should be health care workers, to “try to determine if they have become infected with the virus and likely developed immunity in case they have not presented symptoms."
Information on how the test will be distributed will “likely be communicated this week,” Delgado said.